ArticleExploration of targeted anti-tumor therapy2023

Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.

Melissa Bersanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.